These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23614867)

  • 1. [Ethnicity in pharmacogenetics].
    Sontoredjo TA; de Boer A; Maitland-van der Zee AH
    Ned Tijdschr Geneeskd; 2013; 157(17):A6118. PubMed ID: 23614867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic medications and ethnicity.
    Berg MJ
    J Gend Specif Med; 1998; 1(2):16-7. PubMed ID: 11281006
    [No Abstract]   [Full Text] [Related]  

  • 3. Special report: genotyping for cytochrome P450 polymorphisms to determine drug-metabolizer status.
    Technol Eval Cent Assess Program Exec Summ; 2004 Dec; 19(9):1-2. PubMed ID: 15651132
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease and diabetes in patients with African or Asian background.
    Aambø A; Klemsdal TO
    Tidsskr Nor Laegeforen; 2017 Nov; 137(22):. PubMed ID: 29181932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 pharmacogenetics in African populations: implications for public health.
    Dandara C; Swart M; Mpeta B; Wonkam A; Masimirembwa C
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):769-85. PubMed ID: 24588448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race and medicine.
    Holden C
    Science; 2003 Oct; 302(5645):594-6. PubMed ID: 14576420
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics of antimalarial drugs: effect on metabolism and transport.
    Kerb R; Fux R; Mörike K; Kremsner PG; Gil JP; Gleiter CH; Schwab M
    Lancet Infect Dis; 2009 Dec; 9(12):760-74. PubMed ID: 19926036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of genetic variations of SLC15A2, SLC22A1, SLC22A2 and SLC22A6 genes.
    Cheong HS; Kim HD; Na HS; Kim JO; Kim LH; Kim SH; Bae JS; Chung MW; Shin HD
    J Hum Genet; 2011 Sep; 56(9):666-70. PubMed ID: 21796140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
    Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
    Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interethnic differences in drug response: the contribution of genetic variability in beta adrenergic receptor and cytochrome P4502C9.
    Muszkat M
    Clin Pharmacol Ther; 2007 Aug; 82(2):215-8. PubMed ID: 17329986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferring ethnic origin by means of an STR profile.
    Lowe AL; Urquhart A; Foreman LA; Evett IW
    Forensic Sci Int; 2001 Jun; 119(1):17-22. PubMed ID: 11348789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of principal component analysis to pharmacogenomic studies in Canada.
    Visscher H; Ross CJ; Dubé MP; Brown AM; Phillips MS; Carleton BC; Hayden MR
    Pharmacogenomics J; 2009 Dec; 9(6):362-72. PubMed ID: 19652663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported ethnicity, genetic structure and the impact of population stratification in a multiethnic study.
    Wang H; Haiman CA; Kolonel LN; Henderson BE; Wilkens LR; Le Marchand L; Stram DO
    Hum Genet; 2010 Aug; 128(2):165-77. PubMed ID: 20499252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical practice, race, and drug use.
    Kalow W
    Clin Pharmacol Ther; 2003 Jan; 73(1):132-4. PubMed ID: 12545152
    [No Abstract]   [Full Text] [Related]  

  • 15. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.
    Byeon JY; Kim YH; Lee CM; Kim SH; Chae WK; Jung EH; Choi CI; Jang CG; Lee SY; Bae JW; Lee YJ
    Arch Pharm Res; 2018 Sep; 41(9):921-930. PubMed ID: 30191460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism.
    Farjadian S; Ota M; Inoko H; Ghaderi A
    Mol Biol Rep; 2009 Sep; 36(7):1943-50. PubMed ID: 18979226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paucity of genetic studies of alcohol phenotypes in diverse populations: what are the consequences and opportunities?
    Chartier KG
    Addiction; 2019 Jul; 114(7):1147-1149. PubMed ID: 30537438
    [No Abstract]   [Full Text] [Related]  

  • 18. The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing.
    Chan SL; Suo C; Chia KS; Teo YY
    Pharmacogenomics; 2012 Aug; 13(11):1247-56. PubMed ID: 22920395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group-based pharmacogenetic prediction: is it feasible and do current NHS England ethnic classifications provide appropriate data?
    Ingram CJE; Ekong R; Ansari-Pour N; Bradman N; Swallow DM
    Pharmacogenomics J; 2021 Feb; 21(1):47-59. PubMed ID: 32683419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Factor V Leiden in three ethnic groups of patients with deep vein thrombosis in the Western Cape province of South Africa.
    Rubinstein R; Kolia F; Novitzky N
    Eur J Haematol; 2000 Jul; 65(1):78-9. PubMed ID: 10914945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.